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Abstract
Objective To compare the maternal bone mineral density
(BMD) changes in gestational hypertensive and normoten-
sive pregnancies using quantitative ultrasound.
Methods Consecutive patients were recruited from a gen-
eral obstetric clinic over a period of 9 months. BMD mea-
surements were performed at the os calcis in early
pregnancy before 20 weeks and in the late third trimester
after 36 weeks, using a Hologic Sahara Clinical Bone
Sonometer system. These patients were followed up in
accordance with standard antenatal protocol. The diagnosis
of gestational hypertension (GH) was made based on a
standard institutional protocol. The changes in BMD from
early to late pregnancy were compared between those with/
without GH.
Results A total of 450 patients with complete data were
analyzed. The overall incidence of GH was 4.8% (n = 22),
of which 1.7% (n = 8) fulWlled the deWnitions of severe pre-
eclampsia. A mean BMD loss of 0.0256 g/cm2 (around
4.5% of early pregnancy BMD) was demonstrable from
early to late gestation. The hypertensive group has margin-
ally higher mean BMD loss as compared to the normoten-
sive group (0.052 vs. 0.037 g/cm2; P = 0.037). However,
regression analysis models showed that early pregnancy
BMD values, early pregnancy fat percentage and fat accu-
mulation in pregnancy were signiWcant factors aVecting
BMD loss during pregnancy, while GH was not in the
equations.
Conclusion The development of gestational hypertensive
disorders apparently does not have any signiWcant impact
on BMD changes during pregnancy.
Keywords Bone mineral density · Gestational 
hypertension · Quantitative ultrasound
Introduction
Studies utilizing diVerent methods of assessment, including
radiological [1, 2] and quantitative ultrasound [3, 4], have
been used to study the changes in bone mineral density
(BMD) during pregnancy, and a progressive fall in BMD is
usually demonstrated from the pre-pregnant state to early
postpartum, or from early pregnancy to late pregnancy.
While the factors that would inXuence the magnitude of
BMD changes in pregnancy have been studied in various
settings, the actual patho-physiology involved in such con-
trol is still largely unknown. In particular, few studies have
addressed how particular antenatal complications would
aVect such changes. Gestational hypertension (GH) and
pre-eclampsia are common obstetric problems that would
develop usually during the latter part of the pregnancy. This
study aims at evaluating the diVerences in BMD changes of
the os calcis as measured by quantitative ultrasound from
early to late pregnancy in women with gestational hyper-
tensive disorders, in order to verify whether such conditions
would have an impact on BMD changes in pregnancy.
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A prospective observational study was conducted in a
regional obstetric unit with an annual delivery of around
5,000 deliveries. Consecutive patients with singleton
booked at a general obstetric clinic were recruited over a
9-month period. Routine antenatal care was oVered in accor-
dance with our service protocol. Written consent for quantita-
tive ultrasound BMD measurements of the os calcis was
obtained at the time of recruitment. Basic epidemiological
data, including early pregnancy weight and height, were
recorded. Quantitative ultrasound bone density measure-
ments were performed at the os calcis bilaterally at booking
between 14 and 20 weeks, and in the third trimester
between 36 and 38 weeks. All bone density measurements
were done using the Sahara Clinical Bone Sonometer sys-
tem (Hologic, MA, USA), a waterless portable system that
involved direct contact of the probe with the heel through
elastomer pads and oil based coupling gel. A simulated
BMD value derived from basic speed of sound and bone
ultrasound attenuation parameters was obtained, and this
was used in the subsequent analysis for calculations. The
coeYcient of variation for the estimated heel BMD value
was estimated to be around 2–3% based on the authors’
previous studies utilizing the same system. Body fat per-
centage assay was also performed in each of the two occa-
sions using a Tanita 500 bio-impedance system (Tanita,
Tokyo, Japan). The excitation current introduced into sub-
jects was 800 A, AC at 50 kHz. The analyzer enabled
simultaneous measurements of body weight and impedance
in a subject standing on the stainless steel electrodes with
their bare feet, and calculated the percentage of body fat
based on a two-compartment model of fat mass and lean
body mass. The coeYcient of variation of the system was
quoted as 2.5–3.5% according to the manufacturer. Patients
with other confounding signiWcant medical disorders dur-
ing the antenatal period, including pre-existing medical dis-
orders requiring treatment such as asthma or thyroid
disorders, and those that delivered preterm before 37 weeks
gestation, or who did not complete the second measurement
were excluded from analysis.
Blood pressure was monitored at all regular antenatal
visits, and GH was diagnosed when the pregnant woman
had blood pressure over 140/90 mmHg for two episodes or
more, 6 h apart at gestation 20 weeks or beyond. Pre-
eclampsia was diagnosed when signiWcant proteinuria of
over 300 mg was quantitatively documented in a 24-h urine
sample. Eclampsia referred to patients with the overt clini-
cal observation of an eclamptic Wt superimposed on pre-
eclampsia, and cases with subtle peripheral twitching or
electroencephalographic signs only were excluded. Chronic
hypertension was diagnosed when the woman was docu-
mented to have a blood pressure of over 140/90 mmHg
before 20 weeks or who was diagnosed as hypertensive
before the index pregnancy. Women diagnosed with
chronic hypertension were excluded from the Wnal analysis,
unless there was deWnite clinical evidence of superimposed
pre-eclampsia. The criteria used in the study were adapted
from the local College guidelines and are similar to those of
established consensus standards [5–7].
The occurrence of GH or pre-eclampsia was correlated
with the degree of os calcis BMD changes from early to late
gestation. Other possible confounding factors that might
aVect BMD changes in pregnancy were then analyzed,
including the early pregnancy body mass index, early
pregnancy BMD value, and fat accumulation during preg-
nancy. Univariate analysis of the data was performed by
Chi-square tests for discrete entities, and by paired and
unpaired Student’s t tests for continuous variables where
appropriate, with prior testing for normal distribution of the
data. Parameters found likely to be statistically signiWcant
on univariate analysis were then entered into a logistic
regression model, as well as a multiple regression model,
with BMD loss in pregnancy as the dependent variable.
Data were analyzed using the SPSS version 14.0 (SPSS,
Chicago, IL, USA). A P value of <0.05 was considered sig-
niWcant in this study. The study was approved of by the
Ethics Committee of the local cluster hospital board.
Results
A total of 450 patients with complete data were analyzed.
The overall incidence of GH was 4.8% (n = 22), of which
1.7% (n = 8) fulWlled the deWnitions of severe pre-
eclampsia. The trends in body weight, body mass index
and body fat percentage changes from early to late preg-
nancy were also highly signiWcant (Table 1). A mean
BMD loss of 0.0256 g/cm2 (around 4.5% of early preg-
nancy BMD) was demonstrable from early to late gesta-
tion (Table 1).
There were no signiWcant diVerences in the age, educa-
tion levels or occupation categories between those who
developed GH and those without. A higher proportion in
the GH group was primiparous (82 vs. 47.9%, P = 0.025).
The GH group had signiWcantly higher early pregnancy
weight, body mass index, and body fat percentage, as well
as a marginally higher early pregnancy BMD value
(Table 2). While the mean weight and body fat gain during
pregnancy were not diVerent between the two groups,
the GH group had a marginally higher BMD loss as com-
pared to the normotensive group (0.052 vs. 0.037 g/cm2,
P = 0.037). Within the hypertensive pregnancies, there
were no signiWcant diVerences in BMD loss between those
with GH or pre-eclampsia, probably because of the small
numbers involved.123
Arch Gynecol Obstet (2011) 284:39–44 41A logistic regression analysis model was then con-
structed using the presence/absence of BMD loss as the
dependent variable for the entire cohort. The probable sig-
niWcant parameters suspected clinically or identiWed in the
previous analysis were then entered into the analysis in a
stepwise fashion. The signiWcant factors in the Wnal equa-
tion included only early pregnancy BMD and fat accumu-
lation in pregnancy, while the presence of GH was no
longer a signiWcant parameter. SpeciWcally, a higher early
pregnancy BMD was associated with higher BMD loss,
with an odds ratio (OR) of 19 (conWdence interval 1.3–27),
while a higher fat accumulation in pregnancy was associ-
ated with lower BMD loss (OR 0.83, CI 0.74–0.93)
(Table 3).
The highest mean arterial pressure recorded in the ante-
natal period in each patient was stratiWed into ten intervals
from 70 to 170 mmHg, and then recoded into a “hyperten-
sive index”. This was used as a continuous variable and
entered into a multiple linear regression model together
with other probable parameters, using the BMD change in
pregnancy as the dependent variable. Only early pregnancy
BMD, early pregnancy fat percentage and fat accumulation
Table 1 Changes in anthropometric parameters from early to late pregnancy
P value by paired t tests
SD standard deviation, MD mean diVerence, CI conWdence interval
Early pregnancy 
(<20 weeks) (SD)
Late third trimester 
(36–40 weeks) (SD)
P value; MD (95% CI)
Weight (kg) 56.9 (8.37) 66.6 (8.11) <0.001; 9.78 (9.5 to 10.07)
Body mass index (kg/cm2) 23.2 (3.23) 27.2 (3.08) <0.001; 4.0 (3.88 to 4.11)
Body fat composition (%) 30.5 (5.79) 38 (4.95) <0.001; 7.52 (7.25 to 7.79)
Mean BMD (g/cm2) 0.593 (0.108) 0.567 (0.102) <0.001; ¡0.025 (–0.029 to ¡0.021)
Table 2 Mean anthropometric and BMD changes in those with or without gestational hypertension
BMI body mass index, SD standard deviation, NS no signiWcance, MD mean diVerence, CI conWdence interval
Gestational hypertension (n = 22) Normal (n = 428) P value MD (95% CI)
Age (years) 31.2 (SD 5.29) 31.1 (SD 4.06) 0.93 0.07 (¡1.69 to 1.85)
Height (cm) 156.4 (SD 5.11) 156.4 (SD 5.39) 0.97 ¡0.03 (¡2.35 to 2.28)
Education
Primary 0 (0%) 8 (1.9%) NS
Secondary 18 (82%) 378 (88.3%)
Tertiary 4 (18%) 42 (9.8%)
Parity
Primiparous 18 (81.8%) 223 (52.1%) 0.025
Para 1 4 (18.2%) 182 (42.5%)
Para 2 or higher 0 23 (5.4%)
Occupation
Professional 2 (9%) 10 (2.3%) NS
Clerical 10 (45.5%) 144 (33.7%)
Technical 4 (18.1%) 40 (9.4%)
Service 3 (13.7%) 112 (26.1%)
Manual 0 (0%) 44 (10.3%)
Housewife 3 (13.7%) 78 (18.2%)
Early pregnancy weight (kg) 61.9 (SD 10.6) 56.6 (SD 8.17) 0.004 5.29 (1.73 to 8.86)
Early pregnancy BMI (kg/cm2) 25.3 (SD 4.14) 23.1 (SD 3.14) 0.002 2.17 (0.80 to 3.55)
Early pregnancy body fat (%) 34.7 (SD 6.03) 30.3 (SD 5.70) 0.001 4.47 (2.01 to 6.93)
Early pregnancy BMD (g/cm2) 0.636 (SD 0.086) 0.591 (SD 0.108) 0.053 0.045 (0.0006 to 0.091)
Mean weight gain (kg) 9.35 (SD 2.58) 9.8 (SD 3.11) 0.49 ¡0.45 (¡1.78 to 0.86)
Mean body fat accumulation (%) 7.15 (SD 1.91) 7.61 (SD 2.93) 0.47 ¡0.45 (¡1.05 to 1.40)
Mean BMD loss (g/cm2) 0.052 (SD 0.024) 0.037 (SD 0.034) 0.037 0.015 (0.0009 to 0.029)123
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tion and the hypertensive index was excluded (Table 4).
Discussion
Our data showed an obvious increase in weight and body
fat percentage, as well as a demonstrable progressive fall in
BMD of the os calcis from early pregnancy to late preg-
nancy. Univariate analysis showed a higher BMD loss dur-
ing pregnancy in the gestational hypertensive group, but the
eVects of presence/absence of hypertensive disorders could
not longer be seen on multivariate regression analysis. On
the other hand, anthropometric parameters including early
pregnancy BMD values, and early pregnancy fat percent-
ages and fat accumulation were found to be more important
factors aVecting the extent of BMD loss in pregnancy.
Both GH and pre-eclampsia increases with increasing
BMI and this was also observable in our data. A large retro-
spective cohort over 20 years have shown that increasing
BMI was associated with an increased incidence of pre-
eclampsia as well as other antenatal complications, and that
underweight women actually had better outcomes than
those with normal BMI [8]. As signiWcant diVerences in the
body mass index and early pregnancy body fat composition
were observed in our cohort between those who developed
hypertensive disorders and those who remained normoten-
sive, it could be postulated that these basic anthropometric
parameters were more likely to be responsible for the diVer-
ences in BMD loss observed in pregnancy, rather than the
gestational hypertensive condition.
Direct comparison of BMD loss in pregnancy between
normotensive women and those with hypertensive disor-
ders has only been reported in a few studies in the litera-
ture. In a previous longitudinal study form our group using
the same methodologies to study the general trends in os
calcis BMD in pregnancy, we have a higher but non-signiW-
cant BMD loss in those with GH as compared to non-
hypertensive controls (0.049 vs. 0.039 g/cm2) [9]. An older
study that utilized radiological assessment of the bone den-
sity in the second metacarpal of normal women and those
with pregnancy induced hypertension using the microdensi-
tometry method showed subtle changes in the bone size and
densities at various gestations of the pregnancies, but were
unable to show a clear-cut diVerence in the BMD between
the tow groups [10]. A more recent study that utilized a
similar quantitative ultrasound system also showed a
greater, but non-statistically signiWcant degree of BMD loss
in pre-eclamptic women as compared to normal controls.
The same study also measured the relationship between
insulin-like-growth factor-1 and osteocalcin as markers of
bone turnover, and was able to show an altered relationship
between concentrations of these markers in pre-eclamptic
and normal women [11]. Summing up the data from
these studies, it can be seen that the actual diVerences in
BMD loss between pre-eclamptic and normotensive preg-
nant women, if any, are likely to be marginal or hardly
undetectable.
The relationship between maternal calcium metabolism
in pregnancy and the development of pre-eclamptic disor-
ders has been a controversial issue in the literature. It is
well established that pre-eclampsia is characterized by
endothelial dysfunction related to abnormal trophoblastic
invasion, and a potentially harmful maternal response to a
semi-allogenic fetus that activates inXammatory cells and
oxidative stress pathways, and cytokine proWles [12]. There
Table 3 Logistic regression 
model evaluating the association 
of probably variables with 
presence or absence of bone loss 
from early to late pregnancy
Variable B SE Wald P value OR 95% CI
Age ¡0.046 0.034 1.764 0.18 0.95 0.89–1.02
Body mass index ¡0.036 0.075 0.233 0.62 0.96 0.83–1.11
Early pregnancy fat (%) ¡0.385 0.043 0.797 0.37 0.96 0.88–1.04
Early pregnancy BMD 2.961 1.353 4.784 0.028 19.3 1.36–27.4
Weight gain in pregnancy ¡0.036 0.049 0.525 0.46 0.96 0.87–1.06
Fat gain in pregnancy ¡0.182 0.058 9.693 0.01 0.83 0.74–0.93
Parity 0.385 0.250 2.36 0.12 1.47 0.90–2.40
Gestational hypertension 1.23 0.904 1.86 0.17 3.43 0.58–20.2
SE standard error, OR odds ratio, 
CI conWdence interval
Table 4 Multiple linear regression model evaluating probable factors
aVecting BMD loss in al pregnancies
Gestational hypertension index derived from stratiWed recoding of




Early pregnancy BMI 0.87 1.136 0.25
Early pregnancy BMD 0.228 4.982 0.001
Early pregnancy fat (%) ¡0.19 ¡2.425 0.016
Weight gain in pregnancy ¡0.026 ¡0.508 0.61
Fat accumulation in pregnancy ¡0.191 ¡3.491 0.001
Gestational hypertension index 0.087 1.863 0.063
Parity ¡0.021 ¡0.453 0.65123
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inXammatory cytokines could be associated with decreased
bone mass, clinically detectable osteoporosis and greater
fracture risks in elderly age groups [13]. Calcium supple-
ments have been established as a promising agent for
prophylaxis against pre-eclampsia. In a review of 12 ran-
domized controlled trials, calcium supplementation resulted
in a signiWcant 52% reduction in the relative risk of pre-
eclampsia, with a particularly higher eVect in those with
low calcium intake [14]. When women were screened in
early pregnancy for calcium excretion using a 24 h urine
sample, it was found that those with excessive calcium
excretion might be at risk of GH and pre-eclampsia later on
[15]. In addition, using standard DXA BMD assessment in
a small cohort before pregnancy and in 2 weeks postpartum
period coupled with measurement of calcium intake con-
Wrmed that pregnancy was associated with decreases in
whole-body and regional BMD, but that calcium intake was
not a signiWcant predictor of the skeletal response to preg-
nancy in well-nourished women [16]. Based on these data,
it could be postulated that those with lower calcium
reserves in early pregnancy, and thus higher pre-eclampsia
risks, would also have an altered BMD loss rate because of
their pre-pregnancy or early pregnancy calcium status.
However, whether low calcium intake before or during
pregnancy could be directly translated into subnormal
BMD values into early pregnancy remains to be veriWed.
There were several limitations that can be seen in our
data. While the serial measurements of BMD using quanti-
tative ultrasound is entirely free of radiological hazards,
and thus the ideal method for use during pregnancy, such
systems were known to have a relatively larger coeYcient
of variation of around 2–3%, as compared to BMD mea-
sured using standard radiological methods such as dual
energy X-ray absorptiometry, which gives a coeYcient of
variation of around 1–2% for either short-term or long-term
precision [17]. Thus, it has been argued that Wndings
reported that using these ultrasound methods could be
chance Wndings due to the high system variability. How-
ever, previous studies and our own data have demonstrated
that the Wndings using such quantitative ultrasound has
been consistent and valid when used to assess general BMD
changes in pregnancy [3, 4, 9, 11], or when applied to spe-
ciWc antenatal conditions [18] or coupled with the assay of
biochemical markers of bone metabolism [19]. The magni-
tude of BMD loss in pregnancy has been estimated to be in
the range of 5–6%, and should thus exceed the expected
precision error and the minimal signiWcant measurable
diVerences of these systems. In addition, the incidence of
GH/pre-eclampsia in this cohort was in par with the general
obstetric population incidence, the number of genuine pre-
eclamptics in the cohort was small. It could thus be argued
that this small number of severe cases could attenuate any
observable impact of pre-eclampsia on BMD loss in preg-
nancy, and thus our negative conclusion. A larger cohort
that included more severe pre-eclampsia patients would be
needed to conWrm our results.
We conclude that the diVerences in BMD changes in
pregnancy between those with gestational hypertensive dis-
orders and those who remain normotensive should be small
or negligible. Basic anthropometric parameters such as
obesity that predisposes to GH should be more signiWcant
factors.
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